baicalin has been researched along with Pulmonary Arterial Remodeling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; Li, K; Luan, Y; Qi, T; Sun, C; Wang, J; Xin, Q; Xue, X; Zhang, S | 1 |
| Chao, S; Cheng, GH; Ju, ZY; Kong, F; Luan, Y; Qi, TG; Wang, J; Xue, X | 1 |
2 other study(ies) available for baicalin and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Protective effect of baicalin against pulmonary arterial hypertension vascular remodeling through regulation of TNF-α signaling pathway.
Topics: Actins; Animals; Antihypertensive Agents; Bone Morphogenetic Protein Receptors, Type II; Cell Movement; Cell Proliferation; Cells, Cultured; Flavonoids; Interleukin-1beta; Interleukin-6; Lung; Male; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Rats, Wistar; Signal Transduction; Smad Proteins; Tumor Necrosis Factor-alpha; Vascular Remodeling; Ventricular Function, Right; Ventricular Pressure | 2021 |
Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cytokines; Disease Models, Animal; Flavonoids; Hypertension, Pulmonary; Immunohistochemistry; Lung; Monocrotaline; Pulmonary Artery; Rats, Wistar; Vascular Remodeling | 2015 |